You do know it wasn't consider price sensitive because RAP already announced to the market they were doing clinical trial to screen for COVID-19.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp expands COVID-19 clinical program
Ann: ResApp expands COVID-19 clinical program, page-22
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online